These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12859618)

  • 41. A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin.
    Bains OS; Szeitz A; Lubieniecka JM; Cragg GE; Grigliatti TA; Riggs KW; Reid RE
    J Pharmacol Exp Ther; 2013 Nov; 347(2):375-87. PubMed ID: 23995598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo).
    Belvedere G; Suarato A; Geroni C; Giuliani FC; D'Incalci M
    Biochem Pharmacol; 1989 Nov; 38(21):3713-21. PubMed ID: 2557027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on quinazolinones as dual inhibitors of Pgp and MRP1 in multidrug resistance.
    Wang S; Ryder H; Pretswell I; Depledge P; Milton J; Hancox TC; Dale I; Dangerfield W; Charlton P; Faint R; Dodd R; Hassan S
    Bioorg Med Chem Lett; 2002 Feb; 12(4):571-4. PubMed ID: 11844674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
    Hofland KF; Thougaard AV; Sehested M; Jensen PB
    Clin Cancer Res; 2005 May; 11(10):3915-24. PubMed ID: 15897593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin.
    Nakai K; Takagi Y; Ogawa S; Tsuchiya T
    Carbohydr Res; 1999 Jul; 320(1-2):8-18. PubMed ID: 10515060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment.
    Soares PI; Dias SJ; Novo CM; Ferreira IM; Borges JP
    Mini Rev Med Chem; 2012 Oct; 12(12):1239-49. PubMed ID: 22512558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.
    Szabó I; Manea M; Orbán E; Csámpai A; Bosze S; Szabó R; Tejeda M; Gaál D; Kapuvári B; Przybylski M; Hudecz F; Mezo G
    Bioconjug Chem; 2009 Apr; 20(4):656-65. PubMed ID: 19296605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells.
    Wojcik T; Buczek E; Majzner K; Kolodziejczyk A; Miszczyk J; Kaczara P; Kwiatek W; Baranska M; Szymonski M; Chlopicki S
    Toxicol In Vitro; 2015 Apr; 29(3):512-21. PubMed ID: 25529801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amelioration of adriamycin and daunorubicin myocardial toxicity by adenosine.
    Newman RA; Hacker MP; Krakoff IH
    Cancer Res; 1981 Sep; 41(9 Pt 1):3483-8. PubMed ID: 7260911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells.
    Wang Y; Eksborg S; Lewensohn R; Lindberg A; Liliemark E
    Anticancer Drugs; 1999 Nov; 10(10):921-8. PubMed ID: 10630360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells.
    Hasinoff BB; Yalowich JC; Ling Y; Buss JL
    Anticancer Drugs; 1996 Jul; 7(5):558-67. PubMed ID: 8862724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of S9788, cyclosporin A and verapamil on intracellular accumulation of doxorubicin, daunorubicin and daunorubicinol in primary rat hepatocyte culture].
    Le Bot MA; Kernaleguen D; Simon I; Berlion M; Riché C
    Ann Biol Clin (Paris); 1996; 54(1):21-4. PubMed ID: 8731791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimelanoma activity of chloroquine, an antimalarial agent with high affinity for melanin.
    Inoue S; Hasegawa K; Ito S; Wakamatsu K; Fujita K
    Pigment Cell Res; 1993 Oct; 6(5):354-8. PubMed ID: 8302774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of daunorubicinol in daunorubicin-induced cardiotoxicity as evaluated with the model of isolated perfused rat heart.
    Platel D; Bonoron-Adèle S; Robert J
    Pharmacol Toxicol; 2001 May; 88(5):250-4. PubMed ID: 11393585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
    Aubel-Sadron G; Londos-Gagliardi D
    Biochimie; 1984 May; 66(5):333-52. PubMed ID: 6380596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immediate effects of anticancer drugs on mitochondrial oxygen consumption.
    Souid AK; Tacka KA; Galvan KA; Penefsky HS
    Biochem Pharmacol; 2003 Sep; 66(6):977-87. PubMed ID: 12963484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
    Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
    Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electron spin resonance studies of chloroquine-melanin complexes.
    Buszman E; Kopera M; Wilczok T
    Biochem Pharmacol; 1984 Jan; 33(1):7-11. PubMed ID: 6322795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.